PortfoliosLab logoPortfoliosLab logo
SDEV vs. CRVS
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

SDEV vs. CRVS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Stablecoin Development Corporation (SDEV) and Corvus Pharmaceuticals, Inc. (CRVS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SDEV achieves a -95.92% return, which is significantly lower than CRVS's 72.21% return. Over the past 10 years, SDEV has underperformed CRVS with an annualized return of -59.38%, while CRVS has yielded a comparatively higher 0.31% annualized return.


SDEV

1D
-2.54%
1M
-15.44%
6M
-87.63%
YTD
-95.92%
1Y
-41.37%
3Y*
-76.04%
5Y*
-78.94%
10Y*
-59.38%
ALL TIME*
-49.51%

CRVS

1D
0.53%
1M
-12.93%
6M
-35.94%
YTD
72.21%
1Y
223.41%
3Y*
80.90%
5Y*
44.70%
10Y*
0.31%
ALL TIME*
-1.18%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$10.62M$15.61M$19.34M
$93.45K$1.76M$1.01M

SDEV vs. CRVS - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
SDEV
Stablecoin Development Corporation
-95.92%1,319.69%-91.58%-89.54%-85.21%-45.97%8.91%-17.17%-79.93%16.67%
CRVS
Corvus Pharmaceuticals, Inc.
72.21%43.93%203.98%107.06%-64.73%-32.30%-34.56%48.23%-64.58%-27.55%

Correlation

The correlation between SDEV and CRVS is 0.15, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.15

Correlation (3Y)
Balances recent behavior with more history.

0.13

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.15

Correlation (10Y)
Provides a long-term view across more market conditions.

0.11

Correlation (All Time)
Calculated using the full available price history since Mar 23, 2016

0.10

Fundamentals

Market Cap

SDEV:

$31.18M

CRVS:

$1.12B

EPS

SDEV:

$9.49

CRVS:

-$0.52

PB Ratio

SDEV:

0.28

CRVS:

4.96

Total Revenue (TTM)

SDEV:

$4.67M

CRVS:

$0.00

Gross Profit (TTM)

SDEV:

-$47.00K

CRVS:

-$26.00K

EBITDA (TTM)

SDEV:

-$6.54M

CRVS:

-$47.43M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SDEV vs. CRVS — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

SDEV
SDEV Risk / Return Rank: 4949
Overall Rank
SDEV Sharpe Ratio Rank: 3636
Sharpe Ratio Rank
SDEV Sortino Ratio Rank: 7474
Sortino Ratio Rank
SDEV Omega Ratio Rank: 7373
Omega Ratio Rank
SDEV Calmar Ratio Rank: 3030
Calmar Ratio Rank
SDEV Martin Ratio Rank: 3434
Martin Ratio Rank

CRVS
CRVS Risk / Return Rank: 9090
Overall Rank
CRVS Sharpe Ratio Rank: 8181
Sharpe Ratio Rank
CRVS Sortino Ratio Rank: 9898
Sortino Ratio Rank
CRVS Omega Ratio Rank: 9696
Omega Ratio Rank
CRVS Calmar Ratio Rank: 9191
Calmar Ratio Rank
CRVS Martin Ratio Rank: 8585
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

SDEV vs. CRVS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Stablecoin Development Corporation (SDEV) and Corvus Pharmaceuticals, Inc. (CRVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


SDEVCRVSDifference
Sharpe ratioReturn per unit of total volatility

-1.39

Sortino ratioReturn per unit of downside risk

-2.92

Omega ratioGain probability vs. loss probability

1.21

1.53

-0.32

Calmar ratioReturn relative to maximum drawdown

-0.41

3.89

-4.30

Martin ratioReturn relative to average drawdown

-0.52

7.16

-7.68

SDEV vs. CRVS - Sharpe Ratio Comparison

The current SDEV Sharpe Ratio is -0.16, which is lower than the CRVS Sharpe Ratio of 1.22. The chart below compares the historical Sharpe Ratios of SDEV and CRVS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

SDEV vs. CRVS - Drawdown Comparison

The maximum SDEV drawdown since its inception was -100.00%, roughly equal to the maximum CRVS drawdown of -96.97%. Use the drawdown chart below to compare losses from any high point for SDEV and CRVS.


Loading charts...

Drawdown Indicators


SDEVCRVSDifference

Max Drawdown

Largest peak-to-trough decline

-100.00%

-96.97%

-3.03%

Max Drawdown (1Y)

Largest decline over 1 year

-98.95%

-56.43%

-42.52%

Max Drawdown (3Y)

Largest decline over 3 years

-98.95%

-70.50%

-28.45%

Max Drawdown (5Y)

Largest decline over 5 years

-99.96%

-92.40%

-7.56%

Max Drawdown (10Y)

Largest decline over 10 years

-100.00%

-96.97%

-3.03%

Current Drawdown

Current decline from peak

-100.00%

-48.04%

-51.96%

Average Drawdown

Average peak-to-trough decline

-83.58%

-68.98%

-14.60%

Ulcer Index

Depth and duration of drawdowns from previous peaks

76.67%

30.61%

+46.06%

Volatility

SDEV vs. CRVS - Volatility Comparison

Stablecoin Development Corporation (SDEV) has a higher volatility of 40.24% compared to Corvus Pharmaceuticals, Inc. (CRVS) at 14.68%. This indicates that SDEV's price experiences larger fluctuations and is considered to be riskier than CRVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SDEVCRVSDifference

Volatility (1M)

Calculated over the trailing 1-month period

40.24%

14.68%

+25.56%

Volatility (6M)

Calculated over the trailing 6-month period

103.03%

48.65%

+54.38%

Volatility (1Y)

Calculated over the trailing 1-year period

247.92%

179.50%

+68.42%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

141.40%

131.08%

+10.32%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

333.88%

111.20%

+222.68%

Dividends

SDEV vs. CRVS - Dividend Comparison

SDEV's dividend yield for the trailing twelve months is around 347.83%, while CRVS has not paid dividends to shareholders.


PositionTTM2025
CRVS
Corvus Pharmaceuticals, Inc.
0.00%0.00%
SDEV
Stablecoin Development Corporation
347.83%14.18%

Financials

SDEV vs. CRVS - Financials Comparison

This section allows you to compare key financial metrics between Stablecoin Development Corporation and Corvus Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


SDEV and CRVS have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SDEV has higher volatility (40.24%) compared to CRVS (14.68%). In terms of maximum drawdown, SDEV dropped -100.00% vs CRVS's -96.97%.

CRVS currently has the higher Sharpe Ratio (1.22 vs -0.16), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SDEV and CRVS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer